Bioventus (BVS) Cash from Investing Activities (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bioventus | 535.01 Mn | 544.52 Mn | 90.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 1.03% |
| Dec 31, 2025 | -22.62% |
| Sep 27, 2025 | 65.45% |
| Jun 28, 2025 | -65.74% |
| Mar 29, 2025 | -103.43% |
| Dec 31, 2024 | 37,762.50% |
| Sep 28, 2024 | 16.88% |
| Jun 29, 2024 | 92.30% |
| Mar 30, 2024 | -109.16% |
| Dec 31, 2023 | 636.10% |
| Sep 30, 2023 | -109.26% |
| Jul 1, 2023 | 717.81% |
| Apr 1, 2023 | -4.61% |
| Dec 31, 2022 | 93.96% |
| Oct 1, 2022 | -8.28% |
| Jul 2, 2022 | -1,013.07% |
| Apr 2, 2022 | 97.89% |
| Dec 31, 2021 | -1,578.13% |
| Oct 2, 2021 | -397.96% |
| Jul 3, 2021 | 94.32% |
| Apr 3, 2021 | -2,931.06% |
| Dec 31, 2020 | 91.33% |
| Sep 26, 2020 | -2,264.71% |
| Jun 27, 2020 | -66.52% |